Methicillin Resistance Mechanisms in Staphylococcal Infections

Summary

Staphylococcal species, notably Staphylococcus aureus, resist methicillin and related β-lactam antibiotics primarily through acquisition of the mecA gene carried on mobile genetic elements known as SCCmec. mecA encodes PBP2a, a penicillin-binding protein with reduced affinity for β-lactams, allowing synthesis of a peptidoglycan cell wall despite antibiotic challenge. Multiple SCCmec types vary in genetic content and regulatory elements, influencing resistance level and fitness. Beyond PBP2a, alterations in other penicillin-binding proteins and hyperproduction of β-lactamases contribute to heterogeneous resistance. Enzymes of the Fem (factor essential for methicillin resistance) family construct the characteristic pentaglycine interpeptide bridges of staphylococcal peptidoglycan; variation in these cross-bridges affects cell-wall strength and antibiotic susceptibility. Small-colony variants and biofilm-forming phenotypes confer additional protection by reducing antibiotic penetration and altering metabolic state. Regulatory circuits involving mecR1-mecI and global stress responses fine-tune expression of resistance determinants. This multifaceted resistance architecture underlies the persistence of methicillin-resistant staphylococcal infections in healthcare and community settings, driving ongoing efforts to identify novel inhibitors of PBP2a, Fem enzymes and accessory pathways to restore β-lactam efficacy.

Research from Nature Portfolio

Recent structural and genetic analyses have delineated the essential role of pentaglycine cross-bridges in maintaining S. aureus cell integrity. Conditional depletion of FemA and FemB, key enzymes that sequentially add glycines to the stem peptide, proved lethal, inducing membrane rupture unless osmotic stabilisation was applied. Mutational mapping of FemA’s transferase pocket and α6 helix highlighted residues critical for enzymatic activity but dispensable for membrane localisation, suggesting distinct interfaces for catalysis and targeting. These findings confirm pentaglycine formation as an indispensable resistance cofactor and advocate FemXAB proteins as promising pathogen-specific drug targets to compromise methicillin-resistant strains without widespread collateral effects.

Methicillin Resistance Mechanisms in Staphylococcal Infections publication trend

The graph below shows the total number of articles in methicillin resistance mechanisms in staphylococcal infections across all publications each year (not limited to Nature Index journals).

Technical terms

mecA: Gene encoding PBP2a, the low-affinity penicillin-binding protein central to methicillin resistance.

PBP2a: Alternative transpeptidase that sustains cell-wall synthesis in the presence of β-lactams.

SCCmec: Staphylococcal cassette chromosome mec, a mobile genetic element harbouring mec genes and regulators.

Peptidoglycan: Mesh-like polymer of sugars and peptides forming the bacterial cell wall.

Fem enzymes: Nonribosomal peptidyl transferases (FemX, FemA, FemB) that assemble the pentaglycine interpeptide bridge.

References

  1. The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity. Scientific Reports (2019).
  2. FemABX Family Members Are Novel Nonribosomal Peptidyltransferases and Important Pathogen-specific Drug Targets*. Journal of Biological Chemistry (2000).
  3. FmhA and FmhC of Staphylococcus aureus incorporate serine residues into peptidoglycan cross-bridges. Journal of Biological Chemistry (2020).
  4. Absence of the mecA Gene in Methicillin Resistant Staphylococcus aureus Isolated from Different Clinical Specimens in Shendi City, Sudan. BioMed Research International (2015).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Nature Index 2026 Regenerative medicine
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.